DAFTAR PUSTAKA
1. Ropper AH, Samuels MA. Adams & Victor’s Principles of Neurology: Chapter 31 Intracranial Neoplasm and Paraneoplastic Disorder.9th edition. McGraw-Hill. USA, 2009 2. Kleihus P, Cavence Webster K. Pathology and Genetics of Tumours of the Nervous System. International Agency for Research on Cancer (IARC) World Health Organization. International Society of Neuropathology (ISN), Lyon. 1997. Hal 1-34 3. Groot DJ. Correlative Neuroanatomy. Edisi 21. Appleton & Lange. 1991. Hal 10 4. Louis DN, Ohgaki H, Wiestler OD, et al.: The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114 (2): 97-109, 2007 5. Greenberg SM. Handbook of Neurosurgery: Chapter 21.2.2 Astrocytoma. 7th edition. Thieme. Canada, 2010. Hal 593-596 6. Mahar, M., Proses Neoplasmatik di Susunan Saraf dalam Neurologi Klinis Dasar edisi 5, Dian Rakyat, Jakarta, 2000 : 390 – 402 7. Alex L, Chi-Shing Z, Bernard D, Robert M. 2013. Imaging in Glioblastoma Multiforme. Emedicine. Medscape. http://emedicine.medscape.com. Diakses 25 mei 2018 8. Drive SM. 2013. What is PET? Society of Nuclear Medicine and Molecular Imaging. http://www.snm.org . Diakses 26 mei 2018 9. Jeffrey B, Jules H, Kennedy B. 2013. Improved survival in glioblastoma patients who take bevacizumab
in
Glioblastoma
multiforme.
Emedicine.
Medscape
http://emedicine.medscape.com. Diakses 25 mei 2018 10. Lopes MBS, VandenBerg SR, Scheithauer BW. The World Health Organization classification of nervous system tumors in experimental neuro-oncology. In A.J. Levine
and H.H. Schmidek, eds. Molecular Genetics of Nervous System Tumors Wiley-Liss, New York, pp. 1-36, 1993. http://neurosurgery.mgh.harvard.edu. 11. Matthew J, Khoi D, Jon D,Kaisorn L, B.S, Frank J, Attenello et al. 2009. Gliabel (BCNU) wafer plus concomitant temozolomide therapy after primary resection of glioblastoma multiforme. Journal Of Neurosurgery. Vol 110. No.3. Page: 583-588 12. Preusser M, de Ribaupierre S, Wohrer A, et al. 2011. Current concepts and management of glioblastoma. Ann Neurol.;70(1):9-21. [Medline]. 13. Ryken TC, Frankel B, Julien T, Olson JJ. 2008. Surgical management of newly diagnosed glioblastoma in adults: role of cytoreductive surgery. J Neurooncol.;89(3):271-86. In Improved survival in glioblastoma patients who take bevacizumab in Glioblastoma multiforme. http://emedicine.medscape.com. 14. Sanai N, Berger MS. 2008. Glioma extent of resection and its impact on patient outcome. Neurosurgery.;62(4):753-64; discussion 264-6. [Medline]. 15. Shepard R, 2012. Glioblastoma Multiform. American Association of Neurological Surgeons. http://www.aans.org. 16. Burns DK, Kumar V. The Nervus System In Kumar V, Contran RS, Robin RS, Robbin S, Basic Pathology 7th edition. Saunders. Hal 832-833 17. National Cancer Institute, 2014. Adult Brain Tumors Treatment (PDQ): Treatment Option Overview. United States of America: National Cancer Institute.Tersedia di: http://www.cancer.gov/cancertopics/pdq/treatment/adultbrain/HealthProfessional/page3 18. Ropper AH, Samuels MA. Adams & Victor’s Principles of Neurology: Chapter 31 Intracranial Neoplasm and Paraneoplastic Disorder.9th edition. McGraw-Hill. USA, 2009